Skip to main content
SpringerLink
Log in

β-Adrenoceptor Blocking Drugs and Partial Agonist Activity

Is it Clinically Relevant?

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Aeilig, W.H.: Pindolol — a β-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations. British Journal of Clinical Pharmacology 13: 187S–192S (1982).

    Article  Google Scholar 

  • Ahlquist, R.P.: Present state of α- and β-adrenergic drugs. II. The adrenergic blocking agents. American Heart Journal 92: 804–807 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Barlow, J.J.; Main, B.G.; Moors, J.A.; Nuttall, A. and Snow, H.M.: The cardiovascular activity of ICI 118,587, a novel β-adrenoceptor agonist. British Journal of Pharmacology 67: 412P (1979).

    PubMed  CAS  Google Scholar 

  • Barrett, A.M. and Carter, J.: Comparative chronotropic activity of β-receptor antagonists. British Journal of Pharmacology 40: 373–381 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Benson, M.K.; Berrill, W.T.; Cruickshank, J.M. and Sterling, G.S.: A comparison of four β-adrenoceptor antagonists in patients with asthma. British Journal of Clinical Pharmacology 5: 415–419(1978).

    Article  PubMed  CAS  Google Scholar 

  • Beumer, H.M.: Adverse effects of β-adrenergic receptor blocking drugs on respiratory function. Drugs 7: 130–138 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Bilski, A.; Robertson, H.H. and Wale, J.L.: A study of the relationship between cardiac beta-adrenoceptor blockade and intrinsic sympathomimetic activity in rats depleted of catecholamines. Clinical and Experimental Pharmacology and Physiology 6: 1 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Black, J.W.; Duncan, W.A.M. and Shanks, R.G.: Comparison of some properties of pronethalol and propranolol. British Journal of Pharmacology 25: 577–591 (1965).

    CAS  Google Scholar 

  • Boudoulas, H.; Lewis, R.P.; Kates, R.E. and Dalamangas, G.: Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects. Annals of Internal Medicine 87: 433–436 (1977).

    PubMed  CAS  Google Scholar 

  • Carruthers, S.G.; Kelly, J.G.; McDevitt, D.G. and Shanks, R.G.: Blood levels of practolol after oral and parenteral administration and their relationship to exercise. Clinical Pharmacology and Therapeutics 15: 497–509 (1974).

    PubMed  CAS  Google Scholar 

  • Carruthers, S.G. and Twum-Barima, Y.: Measurement of partial agonist activity of pindolol. Clinical Pharmacology and Therapeutics 30: 581–586 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Chang, L.C.T.: Use of practolol in asthmatics: a plea for caution. Lancet 2: 321 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Christensen, C.C.; Boye, N.P.; Erikson, H. and Hansen, G.: Influence of pindolol (Visken) on respiratory function in 20 asthmatic patients. European Journal of Clinical Pharmacology 13: 9–12 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Clark, B.J.; Menninger, K. and Bertholet, A.: Pindolol — the pharmacology of a partial agonist. British Journal of Clinical Pharmacology 13: 149S–158S (1982).

    Article  PubMed  CAS  Google Scholar 

  • Connolly, C.K. and Batten, J.C.: Comparison of the effect of alprenolol and propranolol on specific airway conductance in asthmatic subjects. British Medical Journal 2: 515–516 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Cocco, G.; Strozzi, C.; Chu, D.; Amrein, R. and Castagnoli, E.: Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischaemia. European Journal of Cardiology 10: 59–69 (1979).

    PubMed  CAS  Google Scholar 

  • Cruickshank, J.M.: Beta-blockers, bradycardia and adverse effects. Acta Therapeutica 7: 309–319 (1981).

    Google Scholar 

  • Davidson, A.C. and Smith, A.C.: Pindolol in orthostatic hypotension. British Medical Journal 282: 1704 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Davies, B.; Bannister, R.; Mathias, C. and Sever, P.: Pindolol in postural hypotension: the case for caution. Lancet 2: 982–983 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Dresel, P.E.: Blockade of some cardiac actions of adrenaline by dichloroisoproterenol. Canadian Journal of Biochemistry and Physiology 38: 375–381 (1960).

    Article  PubMed  CAS  Google Scholar 

  • Ellis, M.E.; Sahay, J.N.; Chatterjee, S.S.; Cruickshank, J.M. and Ellis, S.M.: Cardioselectivity of atenolol in asthmatic patients. European Journal of Clinical Pharmacology 21: 173–176 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Floras, J.S.; Vann Jones, J.; Hassan, M.O. and Sleight, P.: Effect of long-term, once daily administration of atenolol, metoprolol, pindolol and long-acting propranolol on ambulatory blood pressure and its variability in subjects with mild to moderate hypertension. A randomised double-blind trial. Ninth Scientific Meeting of the International Society for Hypertension, Mexico City, p. 118 (1982).

  • Formgren, H.: The effect of metoprolol and practolol on lung function and blood pressure in hypertensive asthmatics. British Journal of Clinical Pharmacology 3: 1007–1014 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Franciosa, J.A.; Johnson, S.M. and Tobian, L.J.: Hemodynamic effects of oxprenolol and propranolol in hypertension. Clinical Pharmacology and Therapeutics 26: 676–681 (1979).

    PubMed  CAS  Google Scholar 

  • Frewin, D.B.; Leonello, P.P.; Penhall, R.K. and Harding, P.E.: Pindolol in orthostatic hypotension. Possible therapy? Medical Journal of Australia 1: 128 (1980).

    PubMed  CAS  Google Scholar 

  • Frishman, W.; Davis, R.; Strom, J.; Elkayam, U.; Stampfer, M.; Ribner, H.; Weinstein, J. and Sonnenblick, E.: Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 5. Pindolol (LB-46) therapy for supraventricular arrhythmia: a viable alternative propranolol in patients with bronchospasm. American Heart Journal 98: 393–398 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Gibson, D.G.: Pharmacodynamic properties of β-adrenoceptor blocking drugs in man; in Avery (Ed.) Cardiovascular Drugs, Vol. 2. β-Adrenoceptor Blocking Drugs, pp. 1–39 (ADIS Press, Sydney 1977).

    Google Scholar 

  • Glaubiger, G. and Lefkowitz, R.J.: Elevated beta-adrenergic receptor number after chronic propranolol treatment. Biochemical and Biophysics Research Communications 78: 720–725 (1977).

    Article  CAS  Google Scholar 

  • Greenblatt, D.J. and Koch-Weser, J.: Clinical toxicity of propranolol and practolol: a report from the Boston Collaborative Drug Surveillance Program; in Avery (Ed.) Cardiovascular Drugs, Vol. 2. β-Adrenoceptor Blocking Drugs, pp. 179–195 (ADIS Press, Sydney 1977).

    Google Scholar 

  • Harry, J.D.; Knapp, M.F.; Linden, R.J.; Newcombe, C.P. and Stoker, J.B.: A test which may demonstrate in man intrinsic sympathomimetic activity of β-adrenoceptor blocking drugs. British Journal of Clinical Pharmacology 2: 374P (1975).

    PubMed  CAS  Google Scholar 

  • Harry, J.D.; Marlow, H.F.; Wardleworth, A.G. and Young, J.: The action of ICI 118,587 (a β-adrenoceptor partial agonist) on the heart rate response to exercise in man. British Journal of Clinical Pharmacology 12: 266P–267P (1981).

    Google Scholar 

  • Hill, R.C. and Turner, P.: Preliminary investigations of a new β-adrenoceptor receptor blocking drug, LB 46, in man. British Journal of Pharmacology 36: 368–372 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Hod, H.; Kaplinsky, N.; Har-Zahav, J. and Frankl, O.: Pindolol-induced tremor. Postgraduate Medical Journal 56: 346–347 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Imhof, P.: The significance of β-blockers, with particular reference to anti-hypertensive treatment. Advances in Clinical Pharmacology 11: 26–32 (1976).

    PubMed  CAS  Google Scholar 

  • Lands, A.M.; Luduena, F.P. and Buzzo, H.J.: Differentiation of receptors responsive to isoproterenol. Life Sciences 6: 2241–2249 (1967).

    Article  PubMed  CAS  Google Scholar 

  • Larsson, S. and Svedmyr, N.: Tremor caused by sympathomimetics is mediated by beta2-adrenoceptors. Scandinavian Journal of Respiratory Diseases 58: 5–10 (1977).

    PubMed  CAS  Google Scholar 

  • McDevitt, D.G.: Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use. Drugs 17: 267–288 (1979).

    Article  PubMed  CAS  Google Scholar 

  • McDevitt, D.G.; Brown, H.C.; Carruthers, S.G. and Shanks, R.G.: Observations on the influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade in man. Clinical Pharmacology and Therapeutics 21: 556–566 (1977).

    PubMed  CAS  Google Scholar 

  • McNeill, J.J. and Louis, W.J.: A double-blind cross-over comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension. British Journal of Clinical Pharmacology 8: 163S–166S (1979).

    Article  Google Scholar 

  • McNeill, R.S.: Effect of a beta-adrenergic blocking agent, propranolol, on asthmatics. Lancet 2: 1101–1102 (1964).

    Article  PubMed  CAS  Google Scholar 

  • McNeill, R.S. and Ingram, C.G.: Effect of propranolol on ventilatory function. American Journal of Cardiology 18: 473–475 (1966).

    Article  PubMed  CAS  Google Scholar 

  • Man in’t Veld, A.J.; Boomsma, F. and Schalekamp, M.A.D.H.: Effects of β-adrenoceptor agonists and antagonists in patients with peripheral autonomic neuropathy. British Journal of Clinical Pharmacology 13: 367S–374S (1982).

    Article  PubMed  Google Scholar 

  • Man in’t Veld, A.J. and Schalekamp, M.A.D.H.: Pindolol acts as a beta-adrenoceptor agonist in orthostatic hypotension: therapeutic implications. British Medical Journal 282: 929–931 (1981).

    Article  Google Scholar 

  • Miller, R.R.; Olson, H.G.; Amsterdam, E.A. and Mason, D.T.: Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of anti-anginal therapy. New England Journal of Medicine 293: 416–418 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Moran, N.C. and Perkins, M.E.: Adrenergic blockade of the mammalian heart by a dichloro analogue of isoproterenol. Journal of Pharmacology and Experimental Therapeutics 124: 223–237 (1958).

    PubMed  CAS  Google Scholar 

  • Myers, M.G.; Freeman, M.R.; Juma, Z.A. and Wisenberg, G.: Propranolol withdrawal in angina pectoris. A prospective study. American Heart Journal 97: 298–302 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Nattai, S.; Rangno, R.E. and Van Loon, G.: Mechanism of propranolol withdrawal phenomena. Circulation 59: 1158–1162 (1979).

    Article  Google Scholar 

  • Nyberg, G.: Pindolol in orthostatic hypotension. British Medical Journal 282: 1704 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Oh, W.M.S.; Kaye, CM.; Warrington, S.J.; Taylor, E.A. and Wadsworth, J.: Studies of cardioselectivity and partial agonist activity in β-adrenoceptor blockade comparing effects on heart rate and peak expiratory flow rate during exercise. British Journal of Clinical Pharmacology 5: 107–120 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Paterson, J.W.: Beta-adrenergic blocking drugs. British Medical Journal 2: 652 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Powles, R.; Shinebourne, E. and Hamer, J.: Selective cardiac sympathetic blockade as an adjunct to bronchodilator therapy. Thorax 24: 616–618 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Prichard, B.N.C.: β-Adrenoceptor blocking drugs in angina pectoris; in Avery (Ed.) Cardiovascular Drugs, Vol. 2. β-Adrenoceptor Blocking Drugs, pp.85–118 (ADIS Press, Sydney 1977).

    Google Scholar 

  • Rangno, R.E. and Langlois S.: Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol. British Journal of Clinical Pharmacology 13: 345S–351S (1982).

    Article  PubMed  CAS  Google Scholar 

  • Rangno, R.E.; Langlois, S. and Lutterodt, A.: Metoprolol withdrawal phenomena: mechanism and prevention. Clinical Pharmacology and Therapeutics 31: 8–15 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Robinson, B.F.; Epstein, S.E.; Beiser, C.D. and Braunwald, E.: Control of the heart rate by the autonomic nervous system: studies in man between baroreceptor mechanisms and exercise. Circulation Research 19: 400–411 (1966).

    Article  PubMed  CAS  Google Scholar 

  • Ronn, O.; Fellinius, E.; Graffner, C.; Johnsson, G.; Lundborg, P. and Svensson, L.: Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta1-adrenoceptor agonist, prenalterol, in man. European Journal of Clinical Pharmacology 17: 81–86 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Ruffin, R.E.; McIntyre, E.L.M.; Latimer, K.M.; Ward, H.E.; Crockett, A.J. and Alpers, J.H.: Assessment of β-adrenoceptor antagonists in asthmatic patients. British Journal of Clinical Pharmacology 13: 325S–335S (1982).

    Article  PubMed  CAS  Google Scholar 

  • Shiroff, R.A.; Mathis, J.; Zelis, R.; Schneck, D.W.; Babb, J.D.; Leaman, D.M. and Hayes, A.H.: Propranolol rebound — a retrospective study. American Journal of Cardiology 41: 778–780 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Simpson, F.O.: β-Adrenoceptor blocking drugs in hypertension; in Avery (Ed.) Cardiovascular Drugs, Vol. 2. β-Adrenoceptor Blocking Drugs, pp.55–83 (ADIS Press, Sydney 1977).

    Google Scholar 

  • Svendsen, T.L.; Carlsen, J.E.; Hartling, O.; McNair, A. and Trap-Jensen, J.: A comparison of the acute haemodynamic effects of propranolol and pindolol at rest and during supine exercise in man. Clinical Science and Molecular Medicine 59: 465S–468S (1980).

    CAS  Google Scholar 

  • Svendsen, T.L.; Hartling, P. and Trap-Jensen, J.: Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers. European Journal of Clinical Pharmacology 15: 223–228 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Svendsen, T.L.; Hartling, O.J.; Trap-Jensen, J.; McNair, A. and Bliddal, J.: Adrenergic beta receptor blockade: haemodynamic importance of intrinsic sympathomimetic activity at rest. Clinical Pharmacology and Therapeutics 29: 711–718 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Szecsi, E.; Kohlschütter, S.; Schiess, W. and Lang, E.: Abrupt withdrawal of pindolol or metoprolol after chronic therapy. British Journal of Clinical Pharmacology 13: 353S–357S (1982).

    Article  PubMed  CAS  Google Scholar 

  • Taylor, S.H.; Silke, B. and Lee, P.S.: Intravenous beta-blockade in coronary heart disease. Is cardioselectivity or intrinsic sympathomimetic activity haemodynamically useful? New England Journal of Medicine 306: 631–635 (1982).

    Article  PubMed  CAS  Google Scholar 

  • Vandenburg, M.J.; Conlon, C. and Ledingham, J.M.: A comparison of the effects of propranolol and oxprenolol on forearm blood flow and skin temperature. British Journal of Clinical Pharmacology 11: 485–490 (1981).

    Article  PubMed  CAS  Google Scholar 

  • Waal-Manning, H.J. and Simpson, F.O.: Practolol treatment in asthmatics. Lancet 2: 1264–1265 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Waiden, R.J.; Bhattacharjee, P.; Tomlinson, B.; Cashin, J.; Graham, B.R. and Prichard, B.N.C.: The effect of intrinsic sympathomimetic activity on β-reeeptor responsiveness after β-adrenoceptor blockade withdrawal. British Journal of Clinical Pharmacology 13: 359S–364S (1982).

    Article  Google Scholar 

  • Wale, J.L.; Conway, A.J. and Reeves, M.: The influence of the intrinsic sympathomimetic activity of beta-adrenoceptor antagonists on haemodynamic effects in anaesthetised dogs. Clinical and Experimental Pharmacology and Physiology 6: 11 (1977).

    Article  Google Scholar 

  • Yusuf, S.; Peto, R.; Bennett, D.; Ramsdale, D.; Furse, L.; Bray, C. and Sleight, P.: Early intravenous atenolol treatment in suspected acute myocardial infarction: preliminary report of a randomised trial. Lancet 2: 273–276 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Zacharias, F.J.; Cowan, K.J.; Cuthbertson, P.J.R.; Johnson, T.B.W.; Prestt, J.; Thompson, J.; Vickers, J.; Simpson, W.T. and Tuson, R.: Atenolol in hypertension: a study of long-term therapy. Postgraduate Medical Journal 53(Suppl. 3): 102–110 (1977).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Therapeutics and Pharmacology, The Queen’s University of Belfast, The Whitla Medical Building, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland

    Denis G. McDevitt

Authors
  1. Denis G. McDevitt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McDevitt, D.G. β-Adrenoceptor Blocking Drugs and Partial Agonist Activity. Drugs 25, 331–338 (1983). https://doi.org/10.2165/00003495-198325040-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198325040-00001

Keywords

Search

Navigation